This is unpublished
PERL: Preventing Early Renal Loss
Completed Studies
Diabetes
AKI
Pinned
Principal Investigator
Ian de Boer
Funding Agency
Joslin Diabetes Center
Status
Completed
Investigator
what is the PERL study?
Preventing Early Renal Loss in Type 1 Diabetes (PERL) Study group is studying a medication called allopurinol to see if it can prevent the loss of kidney function that occurs in about 1 in 5 people with Type 1 diabetes. The study takes place over 3 and a half years and involves 14-17 study visits. Participants take study medication every day and undergo blood testing every 4 months.
Who do I Contact for more information?
Principal Investigator